AKT1 and hepatocellular carcinoma: Knockdown of USP35 resulted in accelerated degradation of ABHD17C, which in turn attenuated the PI3K/AKT pathway, reduced cell proliferation, induced cell cycle arrest, increased apoptosis, and mitigated migration and invasion of HCC cells.